Tslp vaccine for the treatment of th2 mediated inflammatory...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/385 (2006.01) A61K 38/19 (2006.01) C07K 14/52 (2006.01)

Patent

CA 2670460

The invention relates to compositions for the treatment of TH2 mediated inflammatory conditions. The compositions are vaccines comprising a non-primate TSLP or fragments thereof to be used as a vaccine to treat humans with excessive TH2 mediated inflammatory conditions. For the treatment of TH2 mediate inflammatory conditions in other non-human mammals the TSLP of the species to be vaccinated is being used as antigen.

L'invention concerne des compositions destinées au traitement de troubles inflammatoires induits par TH2. Ces compositions consistent en des vaccins contenant un TSLP non primate ou des fragments de celui-ci destiné à être utilisé en tant que vaccin afin de traiter des êtres humains présentant des troubles inflammatoires induits par un excès de TH2. Pour le traitement de troubles inflammatoires induits par TH2 chez les mammifères non humains, le TSLP des espèces à vacciner est utilisé en tant qu'antigène.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tslp vaccine for the treatment of th2 mediated inflammatory... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tslp vaccine for the treatment of th2 mediated inflammatory..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tslp vaccine for the treatment of th2 mediated inflammatory... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1779256

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.